Inhibrx Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inhibrx Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-2.84 | $-3.38 | 16.0 % |
Jun 2024 | 2024-08-13 | $125.48 | $-1.47 | 8636.0 % |
Mar 2024 | 2024-05-09 | $-1.44 | $-1.51 | 4.64 % |
Dec 2023 | 2024-02-28 | $-1.73 | $-1.04 | -66.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-28 | $1.63M | $50.00K | 3168.0 % |
Mar 2023 | 2023-05-08 | $17.00K | $150.00K | -88.7 % |
Dec 2022 | 2023-03-06 | $274.00K | $790.00K | -65.3 % |
Sep 2022 | 2022-11-07 | $278.00K | $630.00K | -55.9 % |
Inhibrx Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Inhibrx Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-2.84, which beat the estimate of $-3.38.
Inhibrx Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.